Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia
Clinical trial NCT01779167 · TERMINATED
Trial details
- NCT number
- NCT01779167
- Sponsor
- Weill Medical College of Cornell University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-10-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.